Marker chromosome is a strong poor prognosis factor after allogeneic HSCT for adverse-risk AML patients.

Kyoko FuseTomoyuki TanakaYasuhiko ShibasakiTatsuo FurukawaMiwako NaritaHirohito SoneMasayoshi Masuko

Published in: European journal of haematology (2020)

Our study suggests MC as a new independent factor for chromosome risk classification to further classify AD-AML.

Keyphrases